These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 11992417)
21. [HSV-TK gene therapy of lung adenocarcinoma xenografts using a hypoxia/radiation dual-sensitive promoter]. Wang WD; Chen ZT; Li DZ; Duan YZ; Wang ZX; Cao ZH Ai Zheng; 2004 Jul; 23(7):788-93. PubMed ID: 15248913 [TBL] [Abstract][Full Text] [Related]
22. [In vitro treatment of ovarian cancer cells with cytosine deaminase-thymidine kinase fusion disuicide gene therapy system under the control of human telomerase reverse transcriptase gene promoter]. Kong BH; Song Y; Ma DX; Qu X; Jiang S Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):390-5. PubMed ID: 15312323 [TBL] [Abstract][Full Text] [Related]
23. Differential regulation of the human sodium/iodide symporter gene promoter in papillary thyroid carcinoma cell lines and normal thyroid cells. Kogai T; Hershman JM; Motomura K; Endo T; Onaya T; Brent GA Endocrinology; 2001 Aug; 142(8):3369-79. PubMed ID: 11459780 [TBL] [Abstract][Full Text] [Related]
24. Construction of gene therapy vectors targeting adrenocortical cells: enhancement of activity and specificity with agents modulating the cyclic adenosine 3',5'-monophosphate pathway. Chuman Y; Zhan Z; Fojo T J Clin Endocrinol Metab; 2000 Jan; 85(1):253-62. PubMed ID: 10634396 [TBL] [Abstract][Full Text] [Related]
25. Gene therapy of established medullary thyroid carcinoma with herpes simplex viral thymidine kinase in a rat tumor model: relationship of bystander effect and antitumor efficacy. Zhang R; DeGroot LJ Thyroid; 2000 Apr; 10(4):313-9. PubMed ID: 10807059 [TBL] [Abstract][Full Text] [Related]
26. Therapeutic efficacy of the suicide gene driven by the promoter of vascular endothelial growth factor gene against hypoxic tumor cells. Koshikawa N; Takenaga K; Tagawa M; Sakiyama S Cancer Res; 2000 Jun; 60(11):2936-41. PubMed ID: 10850440 [TBL] [Abstract][Full Text] [Related]
27. Distinct functional properties of three human paired-box-protein, PAX8, isoforms generated by alternative splicing in thyroid, kidney and Wilms' tumors. Poleev A; Wendler F; Fickenscher H; Zannini MS; Yaginuma K; Abbott C; Plachov D Eur J Biochem; 1995 Mar; 228(3):899-911. PubMed ID: 7737192 [TBL] [Abstract][Full Text] [Related]
28. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector. Latham JP; Searle PF; Mautner V; James ND Cancer Res; 2000 Jan; 60(2):334-41. PubMed ID: 10667585 [TBL] [Abstract][Full Text] [Related]
29. Activation of nicotinamide N-methyltransferase gene promoter by hepatocyte nuclear factor-1beta in human papillary thyroid cancer cells. Xu J; Capezzone M; Xu X; Hershman JM Mol Endocrinol; 2005 Feb; 19(2):527-39. PubMed ID: 15486044 [TBL] [Abstract][Full Text] [Related]
30. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 1. Flt3 ligand gene transfer increases antitumor effects of a radio-inducible suicide gene therapy in an ectopic tumor model. Kawashita Y; Deb NJ; Garg M; Kabarriti R; Alfieri A; Takahashi M; Roy-Chowdhury J; Guha C Radiat Res; 2014 Aug; 182(2):191-200. PubMed ID: 24972258 [TBL] [Abstract][Full Text] [Related]
31. Virus-mediated oncolysis of thyroid cancer by a replication-selective adenovirus driven by a thyroglobulin promoter-enhancer region. Kesmodel S; Prabakaran I; Canter R; Menon C; Molnar-Kimber K; Fraker D J Clin Endocrinol Metab; 2005 Jun; 90(6):3440-8. PubMed ID: 15797967 [TBL] [Abstract][Full Text] [Related]
32. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer. Tang Q; Zhang D; Wan M; Jin L Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766 [TBL] [Abstract][Full Text] [Related]
33. Differential chemosensitivity of breast cancer cells to ganciclovir treatment following adenovirus-mediated herpes simplex virus thymidine kinase gene transfer. Li PX; Ngo D; Brade AM; Klamut HJ Cancer Gene Ther; 1999; 6(2):179-90. PubMed ID: 10195885 [TBL] [Abstract][Full Text] [Related]
34. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters. Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218 [TBL] [Abstract][Full Text] [Related]
35. Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression. Kaneko S; Hallenbeck P; Kotani T; Nakabayashi H; McGarrity G; Tamaoki T; Anderson WF; Chiang YL Cancer Res; 1995 Nov; 55(22):5283-7. PubMed ID: 7585589 [TBL] [Abstract][Full Text] [Related]
36. Radioiodine therapy of thyroid carcinoma following Pax-8 gene transfer. Mu D; Huang R; Ma X; Li S; Kuang A Gene Ther; 2012 Apr; 19(4):435-42. PubMed ID: 21833035 [TBL] [Abstract][Full Text] [Related]
37. [The adenovirus-mediated HSV-TK/GCV suicide gene system in the treatment of tongue carcinoma cell line]. Huang H; Wang A Zhonghua Kou Qiang Yi Xue Za Zhi; 2001 Nov; 36(6):457-60. PubMed ID: 11930726 [TBL] [Abstract][Full Text] [Related]
38. Adenovirus-mediated HSV-TK gene therapy using the human telomerase promoter induced apoptosis of small cell lung cancer cell line. Song JS; Kim HP Oncol Rep; 2004 Aug; 12(2):443-7. PubMed ID: 15254714 [TBL] [Abstract][Full Text] [Related]
39. Growth factor-induced transcription via the serum response element is inhibited by cyclic adenosine 3',5'-monophosphate in MCF-7 breast cancer cells. Lowe WL; Fu R; Banko M Endocrinology; 1997 Jun; 138(6):2219-26. PubMed ID: 9165004 [TBL] [Abstract][Full Text] [Related]
40. Gene therapy of experimental malignant mesothelioma using adenovirus vectors encoding the HSVtk gene. Esandi MC; van Someren GD; Vincent AJ; van Bekkum DW; Valerio D; Bout A; Noteboom JL Gene Ther; 1997 Apr; 4(4):280-7. PubMed ID: 9176512 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]